Phase II study of Lenalidomide in MCL

Results of the MCL-002 (SPRINT) Study (Abstract 626). At ASH 2014, Dr. Marek Trneny discussed his abstract titled Phase II Randomized, Multicenter Study of Lenalidomide Vs Best Investigator’s Choice ... Author: feeds Added: 04/15/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts